Nevertheless, recent works are all in agreement with the conclusion proposed, with the suppression of ABC transporters such as ABCA1 [71], ABCC1 [89], ABCG2 [90], and ABCB1 [90,91,92,93,94] improving the efficacy of TMZ treatment in GBM. The gene discussed is ABCB1; the disease is glioblastoma.